Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEISB.L Regulatory News (EISB)

  • There is currently no data for EISB

Second Completion - Secured Convertible Loan Notes

7 Nov 2023 07:00

RNS Number : 5629S
East Imperial PLC
07 November 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE UK VERSION OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. UPON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

7 November 2023

East Imperial plc (the "Company")

 

Second Completion - 10% Secured Convertible Loan Notes ("2025 Convertible Loan Notes")

East Imperial, the global purveyor of ultra-premium beverages, is pleased to announce that further to the issue of £1,466,666.67 of 2025 Convertible Loan Notes to INL Investment Limited on 14 August 2023 ("First Completion") and the announcement on 17 July 2023, the Company has now issued a further £733,333.33 of 2025 Convertible Loan Notes under the second tranche of the investment ("Second Completion").

 

The Company has also granted INL Investment Limited security over the Company's wholly owned Singapore incorporated subsidiary and Tony Burt, the Company's chief executive officer, has granted a charge over 47,645,448 ordinary shares of £0.01 each in the capital of the Company held by him representing 14.1 per cent. of the issued share capital.

 

INL Investment Limited has the right to convert the 2025 Convertible Loan Notes, including the rolled-up 10% interest thereon, into ordinary shares of £0.01 each in the Capital of the Company ("Ordinary Shares") at a price equal to a 20% discount to the 60 day VWAP of the Ordinary Shares as at the date of the conversion notice, subject to a minimum price per Ordinary Share of £0.01 (being the nominal value of the Ordinary Shares) (the "Conversion Price"), at any time after the expiry of the 12 month period commencing on the date of the instrument constituting the 2025 Convertible Loan Notes ("Convertible Loan Note Instrument") until the redemption of the 2025 Convertible Loan Notes in accordance with the terms of the Convertible Loan Note Instrument. The maturity date of the 2025 Convertible Loan Notes is the first business day falling twenty-four months after the date of issue of the relevant 2025 Convertible Loan Notes.

 

No application will be made for the admission of the 2025 Convertible Loan Notes to trading on any recognised securities exchange.

 

As announced on 17 July 2023, the 2025 Convertible Loan Notes will provide additional working capital to support the Company's plans for continued expansion.

 

Enquiries:

Anthony Burt / Andrew Robertson - investors@eastimperial.com

 

 

1.

Details of the person discharging managerial responsibilities/ person closely associated

a)

Name

Tony Burt

2.

Reason for the notification

a)

Position/status

Chief Executive Officer 

b)

Initial notification/ Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

East Imperial plc

b)

LEI

213800OI98RNUFC3IG61

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 1 pence

Identification code

ISIN: GB00BMZ1ND56

b)

Nature of the transaction

Charge over 47,645,448 ordinary shares held by Tony Burt

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

47,645,448

 

d)

Aggregated information

· Aggregated volume

 

 

47,645,448

· Price

N/A

e)

Date of the transaction

6 November 2023

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IODDZMGMMVFGFZZ
Date   Source Headline
24th Nov 20227:00 amRNSAppointment of US Bottling Partner
17th Oct 202210:00 amRNSTR1 notification
14th Sep 202211:06 amRNSSecond Price Monitoring Extn
14th Sep 202211:00 amRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSInterim results
1st Sep 20227:10 amRNSAppointment of WH Ireland as Joint Broker
12th Aug 20229:05 amRNSSecond Price Monitoring Extn
12th Aug 20229:00 amRNSPrice Monitoring Extension
12th Aug 20227:00 amRNSChina Distribution Agreement
21st Jul 20227:00 amRNSPre-Close Trading Statement
1st Jun 20221:44 pmRNSResult of AGM
27th May 20222:00 pmRNSNotice of AGM: Correction
10th May 20227:00 amRNSPosting of Annual Report and Notice of AGM
5th May 20227:00 amRNSFull Year Results
29th Apr 202212:40 pmRNSShort Delay to Publication of Annual Report
8th Apr 20224:41 pmRNSSecond Price Monitoring Extn
8th Apr 20224:35 pmRNSPrice Monitoring Extension
3rd Mar 20222:05 pmRNSSecond Price Monitoring Extn
3rd Mar 20222:00 pmRNSPrice Monitoring Extension
25th Feb 20228:46 amRNSDirectorship Change
18th Feb 20229:47 amRNSDirector/PDMR Shareholding
19th Jan 20227:00 amRNSUS Distribution Agreement
13th Jan 20227:00 amRNSPlacing and year-end update
10th Dec 20215:00 pmRNSDirector/PDMR Shareholding
9th Dec 20219:00 amRNSDirector/PDMR Shareholding
3rd Dec 20212:23 pmRNSDirectorate Changes and Withdrawal of Requisition
17th Nov 20217:00 amRNSRequisition of Extraordinary General Meeting
5th Nov 20217:00 amRNSSingapore Distribution Partner
1st Nov 20217:00 amRNSAppointment of Head of Sales for North America
19th Oct 20217:00 amRNSAppointments to new Strategic Advisory Board
29th Sep 202112:56 pmRNSShareholder Update
13th Sep 20217:00 amRNSTrading Update
13th Sep 20217:00 amRNSBermele Interim Accounts
7th Sep 20214:41 pmRNSSecond Price Monitoring Extn
7th Sep 20214:36 pmRNSPrice Monitoring Extension
7th Sep 20212:05 pmRNSSecond Price Monitoring Extn
7th Sep 20212:00 pmRNSPrice Monitoring Extension
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
27th Aug 20219:05 amRNSSecond Price Monitoring Extn
27th Aug 20219:00 amRNSPrice Monitoring Extension
27th Aug 20217:37 amRNSNew Supply Agreements
16th Aug 20212:05 pmRNSSecond Price Monitoring Extn
16th Aug 20212:00 pmRNSPrice Monitoring Extension
6th Aug 20217:00 amRNSSupply Agreement
27th Jul 20214:40 pmRNSSecond Price Monitoring Extn
27th Jul 20214:35 pmRNSPrice Monitoring Extension
27th Jul 20212:06 pmRNSSecond Price Monitoring Extn
27th Jul 20212:00 pmRNSPrice Monitoring Extension
23rd Jul 20217:00 amRNSChange of Name

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.